A global phase 3, randomised, double-blind and placebo-controlled study evaluating the efficacy and safety of etavopivat in adolescents and adults with sickle cell disease
2025-05-08
عنوان الدراسة
A global phase 3, randomised, double-blind and placebo-controlled study evaluating the efficacy and safety of etavopivat in adolescents and adults with sickle cell disease
داعم الدراسة
Novo Nordisk
دواء الدراسة
Etavopivat
رقم بروتوكول الدراسة
NN7535-7807
حالة الدراسة
Ongoing
موقع الدراسة
King Abdulaziz Hospital NG (Al Ahsa) ,King Faisal Specialist Hospital and Research Center ,(Riyadh) Imam Abdulrahman Al Faisal Hospital NG (Dammam)
مرحلة الدراسة
3
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.